Eight things to know:
1. About 3 million knee reconstruction surgeries are performed worldwide each year, according to GlobalData.
2. In 2020, 11 percent of knee reconstruction surgeries were performed with robots.
3. The number of robotic-assisted knee reconstruction surgeries is projected to reach about 700,000 by 2030.
4. The market is expected to increase at a compound annual growth rate of 8 percent from 2021 to 2030.
5. The most popular surgical robots for knee reconstruction include Stryker’s Mako, Zimmer Biomet’s Rosa Knee, Smith & Nephew’s Cori, and Johnson & Johnson’s Velys. Combined, these systems control over 95 percent of the U.S. knee robot market.
6. The global knee reconstruction market was valued at $8.4 billion before the COVID-19 pandemic, with Zimmer Biomet controlling about one-third of the market, followed by Johnson & Johnson, Stryker, and Smith & Nephew.
7. None of the smaller orthopedic players have launched robotic systems for knee reconstruction because of technological and financial challenges, according to the report.
8. Zimmer Biomet, Johnson & Johnson, Stryker, and Smith & Nephew are expected to strengthen their hold in the market while robotic-assisted knee procedures increase in popularity.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
